Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development of a Frugal, In Situ Sensor Implementing a Ratiometric Method for Continuous Monitoring of Turbidity in Natural Waters.
Sensors (Basel). 2023 Feb 8;23(4):1897. doi: 10.3390/s23041897.
Sensors (Basel). 2023.
PMID: 36850493
Free PMC article.
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer.
Van Cutsem E, Taieb J, Yaeger R, Yoshino T, Grothey A, Maiello E, Elez E, Dekervel J, Ross P, Ruiz-Casado A, Graham J, Kato T, Ruffinelli JC, André T, Carrière Roussel E, Klauck I, Groc M, Vedovato JC, Tabernero J.
Van Cutsem E, et al. Among authors: groc m.
J Clin Oncol. 2023 May 10;41(14):2628-2637. doi: 10.1200/JCO.22.01693. Epub 2023 Feb 10.
J Clin Oncol. 2023.
PMID: 36763936
Free PMC article.
Clinical Trial.
Item in Clipboard
Data-Driven Subgroup Identification in Confirmatory Clinical Trials.
Bunouf P, Groc M, Dmitrienko A, Lipkovich I.
Bunouf P, et al. Among authors: groc m.
Ther Innov Regul Sci. 2022 Jan;56(1):65-75. doi: 10.1007/s43441-021-00329-1. Epub 2021 Jul 29.
Ther Innov Regul Sci. 2022.
PMID: 34327673
Review.
Item in Clipboard
Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia.
Bitter I, Lieberman JA, Gaudoux F, Sokoloff P, Groc M, Chavda R, Delsol C, Barthe L, Brunner V, Fabre C, Fagard M, Montagne A, Tonner F.
Bitter I, et al. Among authors: groc m.
Neuropsychopharmacology. 2019 Oct;44(11):1917-1924. doi: 10.1038/s41386-019-0355-2. Epub 2019 Mar 1.
Neuropsychopharmacology. 2019.
PMID: 30822774
Free PMC article.
Clinical Trial.
Item in Clipboard
Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial).
Aapro M, Ruiz-Borrego M, Hegg R, Kukielka-Budny B, Morales S, Cinieri S, Freitas-Junior R, Garcia-Estevez L, Szombara E, Borges GS, Passalacqua R, Hervieu H, Groc M, Villanova G.
Aapro M, et al. Among authors: groc m.
Breast. 2019 Jun;45:7-14. doi: 10.1016/j.breast.2019.01.009. Epub 2019 Jan 28.
Breast. 2019.
PMID: 30802822
Clinical Trial.
Item in Clipboard
Cite
Cite